Form 4: Tectonic Therapeutic Officer Exercises Stock Options, Acquires Shares

Marc Schwabish, Chief Business Officer of Tectonic Therapeutic, exercised stock options to acquire 2,700 shares of common stock at $2.38 per share on January 28, 2025.

Summary

• On January 28, 2025, Marc Schwabish, the Chief Business Officer of Tectonic Therapeutic, Inc. (TECX), exercised employee stock options.
• This transaction involved the acquisition of 2,700 shares of common stock at a price of $2.38 per share.
• Following the transaction, Schwabish directly owns 4,700 shares of common stock.
• The exercised options were part of an initial grant that vests over time, with 25% vesting on March 15, 2022, and the remainder vesting in 36 equal monthly installments, contingent upon continued service.
• The options were received in exchange for a stock option to acquire 170,679 shares of common stock pursuant to a merger.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing, reflecting a standard transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the actions of company executives. It is a standard practice for publicly traded companies.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and are required by the SEC to ensure transparency in insider trading.
• The vesting schedule described is a common practice in employee stock option plans to incentivize long-term commitment.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider activity.
• The vesting schedule incentivizes the officer's continued service to the company.

Key Dates